Clinical Trials Browser

Phase 3 × INDUSTRY × Fibroblast Growth Factor 7 × Clear all

NCT00131638 2016-12-16

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Advanced Head and Neck Cancer

Phase 3 Completed

Head and Neck Neoplasms, Neoplasms, Stomatitis

NCT00101582 2016-09-27

Palifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer

Phase 3 Completed

188 enrolled 19 charts

Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Stomatitis, Xerostomia, Oral Ulcer, Mucositis

NCT00434161 2015-03-30

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

Phase 3 Completed

281 enrolled 27 charts

Cataract, Multiple Myeloma, Neoplasms, Stomatitis

NCT00109031 2014-09-15

Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)

Phase 3 Completed

47 enrolled 19 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasms

NCT00041665 2013-05-08

Recombinant Human Keratinocyte Growth Factor to Reduce Oral Mucositis in Hematologic Malignancy Patients Undergoing Peripheral Blood Stem Cell Transplantation After Radiation and High-dose Chemotherapy

Phase 3 Completed

Stomatitis